Ameluz treats actinic keratoses on the face and scalp. It is recommended to avoid exposure to the sun for about 48 hours after treatment.

Ameluz Overview

Reviewed: May 31, 2016

Ameluz is a prescription medication used to treat mild to moderate actinic keratoses on the face and scalp. Ameluz is used in combination with photodynamic therapy (PDT) using BF-RhodoLED. BF-RhodoLED, considered a medical device, is a lamp that produces red light and activates the medication.

Ameluz belongs to a group of drugs called a porphyrin precursor. After being activated by BF-RhodoLED, Ameluz destroys the target cells. 

This medication is available as a gel and is administered by a health care provider. 

Common side effects include applicate site side effects such as pain/burning, irritation, and itching. 


How was your experience with ?

First, a little about yourself

Tell us about yourself in a few words?

What tips would you provide a friend before taking ?

What are you taking for?

Choose one
  • Other

How long have you been taking it?

Choose one
  • Less than a week
  • A couple weeks
  • A month or so
  • A few months
  • A year or so
  • Two years or more

How well did work for you?

Did you experience many side effects while taking this drug?

How likely would you be to recommend to a friend?

Ameluz Drug Class

Ameluz is part of the drug class:


All RxWiki content including health news, medication pages, and condition pages published prior to February 2023, was written and maintained by on-staff pharmacists. Please be advised that this content is no longer actively maintained and may now contain outdated information. If you have any questions regarding previously published content, please contact